Special Consideration for MIGS | ASCRS

Special Consideration for MIGS

Special Consideration For MIGS

Saturday, July 24, 2021, 11:30 – 1 PM

This program will explore the various considerations for MIGS including combining MIGS, standalone MIGS, special cases and next-generation MIGS. The program will conclude with a panel discussion and Q&A with our expert faculty. This program is also part of the  ASCRS Glaucoma Building Blocks Series.

The American Society of Cataract and Refractive Surgery designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™ 

Program Chairs

Leon Herndon

Leon W. Herndon, MD


Manjool Shah, MD


Ike K. Ahmed, MD

Marlene Moster, MD

Marlene R. Moster, MD

Jacob W. Brubaker, MD

Won Kim MD Headshot

Won Kim, MD

Continuing Medical Education (CME) Credits

Accreditation Statement

ACCME Accredited image The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality and scientific integrity of the CME activity.

Designation Statement
The American Society of Cataract and Refractive Surgery designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

All CME activities approved for AMA PRA Category 1 Credit are valid for recognition by the European Accreditation Council for Continuing Medical Education (EACCME). Physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 Credit

Attendees registered as exhibitors, spouses, and guests are not eligible for CME credits.

Educational Objectives

Upon completion of this program, participants should be able to:

  • Compare the various MIGS approaches now and in the pipeline for Glaucoma treatment.


Notice About Off-Label Use Presentations

The webinar may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products or techniques presented.

ADA/Special Accommodations

ASCRS fully complies with the legal requirements of the American with Disabilities Act (ADA) and the rules and regulations thereof. ASCRS also requires ADA compliance from its contracted vendors and facilities. Any participant in this educational program who requires special accommodations or services should contact a staff member.